Spiriva pfizer

25 Jul 2007 Boehringer Ingelheim and Pfizer today announced successful completion of the approval process for authorisation to market Spiriva Boehringer Ingelheim and Pfizer will globally co-promote BI39s Spiriva (tiotropium), a once daily, inhaled bronchodilator to treat chronic obstructive pulmonary

31 Aug 2012 NEW YORK--(BUSINESS WIRE)--Boehringer Ingelheim and Pfizer Inc (NYSE: PFE) announced SPIRIVA amp Exercise Capacity Study (205.440)

Spiriva HandiHaler (tiotropium bromide inhalation powder) is a once-daily inhaled COPD prescription maintenance medicine that can help you breathe 15 Jun 2011 There was some bad news for Boehringer Ingelheim39s Spiriva after the mist inhaler formulation, which is co-marketed by Pfizer for chronic Under the terms of their agreement, BI and Pfizer will conduct additional clinical trials of Spiriva to further develop the product39s potential, and will share global

New Spiriva Respimat inhaler completes European approval

Pfizer RxPathways is a program that provides eligible patients with services including insurance counseling and access to medicines for free or at a savings Researchers are raising new questions about the safety of an respiratory inhaler sold by Boehringer Ingelheim and Pfizer. Patients who use the Spiriva

15 Jun 2011 Boehringer Ingelheim GmbH and Pfizer Inc.39s Spiriva mist inhaler for chronic lung disease may raise the risk of an early death, a review of five Tiotropium bromide capsules for inhalation are co-promoted by Boehringer- Ingelheim and Pfizer under the trade name Spiriva. It is also manufactured and